Thanks for making an appointment
Date and time
2Choose a doctor
3Make an appointment
Date and time
2Choose a doctor
3Make an appointment
A conference in Samarkand devoted to diagnosis and treatment of human papilloma virus (HPV) and its spread in Uzbekistan. - Sputnik Uzbekistan, 1920, 22.07.2022
Cervical cancer is the second most common disease in Uzbekistan.
TASHKENT, July 22 - Sputnik. A conference dedicated to the diagnosis and treatment of human papilloma virus (HPV) and its spread in Uzbekistan is taking place in Samarkand.
Thus, the event is held on July 22-23 and is attended by representatives of the Ministry of Health, Sanitary and Epidemiological Facility, doctors and scientists, KPFIH.
Uzbekistan plans to test 50,000 women for human papillomavirus and cervical cancer in three years. More than 12,000 women have already been screened.
In Uzbekistan, as in the rest of the world, cervical cancer is the second most common among women of all ages. Breast cancer takes the leading place. According to the Global Cancer Observatory database, 1,863 women are diagnosed with cervical cancer annually, and more than 42% of them die. The cause of most deaths is late diagnosis. It is the human papilloma virus that causes cervical cancer, and it is detected in 98-99% of cases.
During the conference, experts noted that cervical cancer is the only cancer that is completely preventable. It develops gradually. The development of the tumor is caused by precancerous diseases. There is enough time for diagnosis and treatment, experts emphasized.
Currently, 50,000 women in Tashkent, Samarkand and Andijan regions will be tested for HPV and cervical cancer in the framework of a pilot project of the Uzbek Health Ministry, the Research Institute of Virology and KOFIH.
To date more than 12,000 women in Tashkent and Andijan oblast have been examined under the project. The virus has been detected in 11% of them. In Andijan region, 6% of women who were screened again were diagnosed with precancerous diseases, and 3% were diagnosed with cervical cancer.
Also at the conference, it was reported that in Samarkand women's screening began in June of this year, so no specific data for that region are available yet.
The project will last until 2024. Through this program, for the first time will study the spread of HPV on a national scale and create a system of early diagnosis of HPV and cervical cancer, as well as develop standards and practical guidelines for detecting the virus, preventing and treating cancer.
Uzbekistan is actively cooperating with foreign partners in healthcare and is developing cooperation with Russia. For example, the Center of Pediatric Oncohematology opened in Tashkent. Also, Uzbek authorities have studied the experience of Rogachev Medical Research Center. In addition, a branch of the Pirogov Russian National Research Medical University will soon open in the republic.
